ACTIVE

MAYAKU PHARMACEUTICAL DEVELOPMENT

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
1,6 k €
-67.5% YoY
Gross margin
104,8 k €
+115.0% YoY
Equity
1,3 k €
+592.4% YoY

What does MAYAKU PHARMACEUTICAL DEVELOPMENT do?

MAYAKU PHARMACEUTICAL DEVELOPMENT is a Private limited company incorporated in 2020. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Gent.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0755.350.975
Incorporation
29/09/2020
Legal form
Private limited company
Registered office
Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map
Contributed capital
2 000,00 €
Latest accounts
31/12/2025
Activities (NACE)
21100Manufacture of basic pharmaceutical products· main21100Manufacture of basic pharmaceutical products21201Manufacture of pharmaceutical preparations21201Manufacture of pharmaceutical preparations21201Manufacture of pharmaceutical preparations21201Manufacture of pharmaceutical preparations+4
Signals
ProfitableGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin104,8 k €48,7 k €-16,7 k €-11,9 k €43,1 k €
EBITDA19,1 k €17,8 k €-17,6 k €-12,1 k €42,6 k €
Operating result4,2 k €6,3 k €-24,0 k €-13,8 k €39,3 k €
Net result1,6 k €4,8 k €-25,5 k €-14,7 k €33,2 k €
Balance sheet
Equity1,3 k €-262,1 €-5,0 k €20,4 k €35,2 k €
Total assets170,5 k €99,1 k €93,1 k €59,2 k €98,4 k €
Cash76,4 k €23,4 k €48,2 k €15,5 k €76,6 k €
Debts169,2 k €99,4 k €98,1 k €38,7 k €63,2 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

Michiel Van Speybroeck

Director

Active

Ended mandates

Michiel Van Speybroeck

Manager

Ended
At this address

Other companies at this address

CompanyCBE no.
Amalus Therapeutics● Bankrupt
0803.929.268
APCOR R&M● Active
0600.952.909
Ardoyen● Active
0875.102.821
AVROXA● Active
0687.774.936
Benebiose● Active
0784.521.548
BioNeering● Active
0807.194.309
CONTREL EUROPE● Active
0426.204.637
CRODEON TECHNOLOGIES● Active
0642.754.761
Cryptobiotix● Active
0762.565.104
Gulliver Biomed● Active
0692.527.837
ImplicitMeasures.com● Bankrupt
0657.989.701
Inbiose● Active
0534.887.593
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT● Active
0440.054.752
INNOVATIVE PHARMACEUTICS● Active
0883.574.582
Inspect● Active
0645.950.417
INVIBES ADVERTISING● Active
0836.533.938
KYTOS● Active
0768.755.286
Lares Solutions● Active
1015.346.906
Microbial Resource Management Health● Active
0742.910.132
Microbial Resource Management Technologies● Active
0667.765.816
Annual accounts

Full financial information

20252024202320222021
Type of accountMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202229/09/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months16 months
Filing date04/07/202627/06/202518/06/202429/06/202319/07/2022
General meeting22/06/202622/06/202501/06/202401/06/202320/06/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

5 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202522/06/202604/07/2026DutchPDF
Micro model31/12/202422/06/202527/06/2025DutchPDF
Micro model31/12/202301/06/202418/06/2024DutchPDF
Micro model31/12/202201/06/202329/06/2023DutchPDF
Micro model31/12/202120/06/202219/07/2022DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

Michiel Van Speybroeck

Director

Active

Ended mandates

Michiel Van Speybroeck

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Registered office28/04/2023
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other01/10/2020
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20251,6 k €↓
  2. 2024
    Annual accounts 20244,8 k €↑
  3. 2023
    Annual accounts 2023-25,5 k €↓
  4. 2022
    Annual accounts 2022-14,7 k €↓
  5. 2021
    Annual accounts 202133,2 k €
  6. 29/09/2020
    IncorporationPrivate limited company